Learning Objectives:
- Understand Cerebral Small Vessel Disease risk factors and their impact on pathophysiology
- Recognize Cerebral Small Vessel Disease neuroimaging and its relevance for patient outcomes
- Evaluate drug and lifestyle approaches for Cerebral Small Vessel Disease management.
Scientific Program:
- Chair Introductions, Bo Norrving
- Epidemiology, risk factors & pathophysiology, Christopher Chen
- Neuroimaging and clinical implications, Simon Frandler-Höfler
- Pharmacological and lifestyle interventions, Joanna Wardlaw
- Q&A Discussion, moderated by Anna Bersano
- Closing Remarks, World Stroke Academy
Date and Time: November 16th, 3pm (CET)
16 ноя 2023
